CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.15
0.05 (1.22%)
▲
5d:
-9.78%
30d:
-8.79%
90d:
+15.28%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 7, 2026 at $4.76 · last confirmed Aug 17, 2026
Strength: 5.1/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.15, which is considered oversold relative to its 30-day fair value range of $4.23 to $4.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.7) compared to its historical average (36.4). Remarkably, the market is currently pricing in an annual earnings decline of 8.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLOV scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.17 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLOV scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.17 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.23 -
$4.64
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (24/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.5% below Wall St target ($5.17)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.23 -
$4.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.09
Resistance Level
$4.79
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.67
Wall Street Target
$5.17
(+24.5%)
Revenue Growth (YoY)
55.6%
Profit Margin
-0.7%
Valuation Discount vs History
-8.7% cheaper
PE vs Historical
27.7 vs 36.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.7%
(market-implied from PE analysis)
1-Year Target
$3.79
(-9%)
2-Year Target
$3.46
(-17%)
3-Year Target
$3.16
(-24%)
3-Yr Target (if PE normalizes)
(PE: 28→36)
$4.16
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.7, Growth: 7.1%)
$5.10
(+23%)
Base:
(SPY PE: 20.1, Growth: 7.1%)
$3.70
(-11%)
Bear:
(PE: 17.1, Growth: 7.1%)
$3.15
(-24%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.7 to 36.4
Stabilization Target:
$5.46
(+31.6%)
PE Expansion Potential:
+31.6%
Share & Embed Analysis
Last updated: August 23, 2026 8:00 AM ET
Data refreshes hourly during market hours. Next update: 9:00 AM
Data refreshes hourly during market hours. Next update: 9:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 65 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 48 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 54 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$416 | 60 BUY |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
